Hikma Pharmaceuticals Share Discussion Threads

[r ball] 22/7/2016 12:20

Sorry. meant GBP hedge. as £ drops share price rises.

[rrb] 22/7/2016 10:57

how can a company earning in USD with a large cost base in USD and reporting in USD be a USD hedge?!

[r ball] 21/7/2016 06:31

Gets better. Fwiw. Look at fx effect on halma

[r ball] 20/7/2016 18:09

I'm alone here.

[r ball] 15/7/2016 17:37

Inverse relationship to nos of posts

[mrthomas] 15/7/2016 09:12

and that as well looking to keep this a a long term hold if possible but am surprised at how little following has

[mrthomas] 06/7/2016 17:26

Agree these are doing very well and saw a report from a good broker saying they impressed with the company and see more upside which is good

[r ball] 01/7/2016 14:54

staggeringly few comments.

[broadwood] 01/7/2016 10:52

They entered the FTSE 100 on 20 June.

Fund buying to adjust weightings.

[r ball] 01/7/2016 10:46

there is a lot m ore to go here. Watch sector rotation from property into pharma.

also watch for more business friendly climate. PPI deadline (coming), Living wage (abandoned) etc.

[mrthomas] 01/7/2016 09:51

could be Middle East factor but done very well on this share in past 4 months see your logic re ex rate $ taking to higher at least will keep it in Top 100

[r ball] 30/6/2016 20:59

£28 target (well £25 using last weeks $ krona rate)

[r ball] 30/6/2016 17:47

why is this share so overlooked??

[r ball] 28/6/2016 17:35

Its a $ hedge with a stable income stream. Expecting it to be up 15% in current market.

More upside to come.

More to go.

[mrthomas] 28/6/2016 12:37

Be surprised how well doing was thinking of selling as done very well on this stock in 4 months

[r ball] 28/6/2016 10:38

safe haven. $ denominated earnings.

[broadwood] 06/6/2016 14:18

Jordanian drugs-maker Hikma became the fourth pharma constituent of the FTSE 100 in March 2015, before falling out of favour with investors and dropping out of the top index a year later. But a recent positive trading statement has seen the share price rally enormously and last month the group rejoined the FTSE 100 having replaced satellite firm Insmarsat.

[r ball] 02/6/2016 18:35

quite. hold.ps; ftse up 0.8% in past 12 months. if you beat this you are doing very very well

[broadwood] 02/6/2016 06:32

Should keep bubbling along as Fund Managers up their weightings.

Hikma Pharmaceuticals is set to enter the FTSE 100 index as satellite firm Inmarsat drops to the FTSE 250.

The changes will take effect on June 20, London Stock Exchange said today.

Hikma Pharmaceuticals's promotion to Britain's blue chip index comes after its shares surged 45 per cent since mid-March. The company expects its full year group revenue to be between $2bn (£1.3bn) and $2.1bn (£1.4bn

[mrthomas] 31/5/2016 10:29

as I said before surprised how few comments I made over 25% in just under 3 months am hoping it get back to top 100 and this could be a long term hold.
My daughter worked for them three months in Jordan and did not like them at all but as an investment they doing well

[r ball] 31/5/2016 09:09

What no comments?

[r ball] 17/5/2016 05:26

in line update. trend continues. £25

[r ball] 12/5/2016 08:26

excellent news. I would hate them the over promise.

[broadwood] 12/5/2016 06:20

Hikma reiterates guidance